Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Acute Inflammation II: Cellular Phase

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II study.

Blood advances·2026

Same author

Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients.

Bone marrow transplantation·2026

Same author

Transplantation outcomes in patients with Down syndrome-associated acute lymphoblastic leukaemia: Implications for treatment intensity and the use of novel therapies.

British journal of haematology·2026

Same author

Bidirectional associations between bacteraemia and cytomegalovirus infection after allogeneic haematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy Transplant Complications Working Group.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Same author

Utility of transplant conditioning intensity score in allogeneic haematopoietic stem cell transplantation for genetic disorders.

British journal of haematology·2026

Same author

Impact of Conditioning Regimen Type on Outcomes in Pediatric Patients with De Novo Advanced Myelodysplastic Syndrome Undergoing Hematopoietic Stem Cell Transplantation.

Transplantation and cellular therapy·2025

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

[Acute myeloid leukemia].

¹Division of Hemato-oncology and Regeneration Medicine, Kanagawa Children Medical Center.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|February 16, 2007

Summary

Pediatric acute myeloid leukemia (AML) survival rates improved with risk-adapted therapy. Identifying prognostic factors like chromosomal abnormalities and genetic mutations guides tailored AML treatment strategies for better outcomes in children.

Area of Science:

Pediatric Hematology/Oncology
Cancer Genetics and Genomics
Clinical Trial Design

Context:

Pediatric acute myeloid leukemia (AML) incidence varies globally, with Japan reporting higher rates than the USA and Europe.
Significant advancements have improved long-term survival for pediatric AML patients, exceeding 50% in the USA and Europe.
Understanding prognostic factors is crucial for stratifying risk and personalizing AML treatment in children.

Purpose:

To analyze prognostic factors in pediatric AML and classify patients accordingly.
To evaluate the efficacy and safety of risk-stratified treatment strategies in newly diagnosed pediatric AML.
To assess the impact of genetic mutations (e.g., FLT3/ITD) and chromosomal abnormalities on AML prognosis.

Summary:

More Related Videos

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Related Experiment Videos

Last Updated: Jul 16, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Specific chromosomal translocations (t(15;17), inv(16), t(8;21)) predict a favorable prognosis, while monosomy 7, monosomy 5, and del(5q) indicate a poor prognosis.

FLT3/ITD mutations are associated with a particularly poor prognosis in pediatric AML.

Risk-adapted therapy, incorporating quality of life considerations, has led to high survival rates, such as 79% at 3 years in the AML 99 trial.

Impact:

Establishes the importance of risk stratification based on leukemia cell biology and initial treatment response for optimizing pediatric AML therapy.
Highlights the success of risk-adapted therapeutic strategies in improving survival rates for childhood de novo AML.
Informs future clinical trial design and treatment protocols for pediatric AML, aiming for enhanced efficacy and safety.